Detalhe da pesquisa
1.
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry.
Ophthalmology
; 128(6): 910-919, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33166553
2.
Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade.
J Neuroophthalmol
; 41(4): 519-530, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33136674
3.
Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
J Neurooncol
; 147(1): 15-24, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31981014
4.
Markers of nonselective and specific NK cell activation.
J Immunol
; 190(12): 6269-76, 2013 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23656738
5.
Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment.
Am J Ophthalmol
; 224: 282-291, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33359682
6.
Three-dimensional Imaging Coupled with Topological Quantification Uncovers Retinal Vascular Plexuses Undergoing Obliteration.
Theranostics
; 11(3): 1162-1175, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33391527
7.
Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition.
Ocul Immunol Inflamm
; 28(2): 217-227, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-30821569
8.
Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
Invest Ophthalmol Vis Sci
; 60(1): 245-254, 2019 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30646013
9.
Implications of Birdshot-Like Uveitis on the Pathogenesis of Birdshot Chorioretinopathy.
JAMA Ophthalmol
; 137(5): 583-584, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30869756